clenbuterol has been researched along with Insulin Sensitivity in 11 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was conducted to determine the effect of chronic administration of the long-acting beta(2)-adrenergic agonist clenbuterol on rats that are genetically prone to insulin resistance and impaired glucose tolerance." | 7.71 | Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. ( Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ, 2001) |
| "This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats." | 7.68 | Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. ( Banks, EA; Brozinick, JT; Cortez, MY; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "Clenbuterol was given as 2 intramuscular injections with an interval of about 12 h." | 5.30 | Clenbuterol-induced insulin resistance in calves measured by hyperinsulinemic, euglycemic clamp technique. ( Hänni, A; Jacobsson, SO; Luthman, J; Sternbauer, K, 1998) |
| "C57Bl/6N mice with diet-induced obesity were treated both acutely and for up to 42 days with a wide range of clenbuterol dosages and treatment durations." | 3.96 | Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity. ( Åslund, A; Bengtsson, T; Berlin, R; Dehvari, N; Forsberg, E; Halleskog, C; Hoeks, J; Kalinovich, A; Olsen, J; Östenson, CG; Rinde, M; Sandström, A; Schaart, G; van Beek, S; Zacharewicz, E, 2020) |
| "The present study was conducted to determine the effect of chronic administration of the long-acting beta(2)-adrenergic agonist clenbuterol on rats that are genetically prone to insulin resistance and impaired glucose tolerance." | 3.71 | Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. ( Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ, 2001) |
| "A possible mechanism by which chronic clenbuterol treatment causes multiple physiological changes in skeletal muscle that leads to reduced insulin resistance in the obese Zucker rat (falfa) was investigated." | 3.71 | Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions. ( Castle, A; Ivy, JL; Kuo, CH; Yaspelkis, BB, 2001) |
| "The effects of aerobic exercise training, chronic administration of the selective beta 2-adrenergic agonist clenbuterol, and the combination of these two treatments on muscle insulin resistance were compared in female obese (fa/fa) Zucker rats." | 3.68 | Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle. ( Brozinick, JT; Etgen, GJ; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats." | 3.68 | Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. ( Banks, EA; Brozinick, JT; Cortez, MY; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "Previous studies in fetuses with intrauterine growth restriction (IUGR) have shown that adrenergic dysregulation was associated with low insulin concentrations and greater insulin sensitivity." | 1.51 | Postnatal β2 adrenergic treatment improves insulin sensitivity in lambs with IUGR but not persistent defects in pancreatic islets or skeletal muscle. ( Allen, RE; Anderson, MJ; Antolic, AT; Camacho, LE; Davis, MA; Goyal, R; Hay, WW; Kelly, AC; Limesand, SW; Papas, KK; Steyn, LV; Yates, DT, 2019) |
| "Clenbuterol was given as 2 intramuscular injections with an interval of about 12 h." | 1.30 | Clenbuterol-induced insulin resistance in calves measured by hyperinsulinemic, euglycemic clamp technique. ( Hänni, A; Jacobsson, SO; Luthman, J; Sternbauer, K, 1998) |
| "Clenbuterol treatment did, however, increase citrate synthase activity and GLUT-4 protein in soleus." | 1.29 | Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle. ( Etgen, GJ; Ivy, JL; Kang, HY; Torgan, CE, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Meister, J | 2 |
| Bone, DBJ | 2 |
| Knudsen, JR | 2 |
| Barella, LF | 2 |
| Liu, L | 1 |
| Lee, R | 1 |
| Gavrilova, O | 2 |
| Chen, M | 2 |
| Weinstein, LS | 2 |
| Kleinert, M | 2 |
| Jensen, TE | 2 |
| Wess, J | 2 |
| Velenosi, TJ | 1 |
| Akhmedov, D | 1 |
| Lee, RJ | 1 |
| Cohen, AH | 1 |
| Cui, Y | 1 |
| Karsenty, G | 1 |
| Berdeaux, R | 1 |
| Richter, EA | 1 |
| Yates, DT | 1 |
| Camacho, LE | 1 |
| Kelly, AC | 1 |
| Steyn, LV | 1 |
| Davis, MA | 1 |
| Antolic, AT | 1 |
| Anderson, MJ | 1 |
| Goyal, R | 1 |
| Allen, RE | 1 |
| Papas, KK | 1 |
| Hay, WW | 1 |
| Limesand, SW | 1 |
| Kalinovich, A | 1 |
| Dehvari, N | 1 |
| Åslund, A | 1 |
| van Beek, S | 1 |
| Halleskog, C | 1 |
| Olsen, J | 1 |
| Forsberg, E | 1 |
| Zacharewicz, E | 1 |
| Schaart, G | 1 |
| Rinde, M | 1 |
| Sandström, A | 1 |
| Berlin, R | 1 |
| Östenson, CG | 1 |
| Hoeks, J | 1 |
| Bengtsson, T | 1 |
| Torgan, CE | 3 |
| Etgen, GJ | 2 |
| Kang, HY | 1 |
| Ivy, JL | 5 |
| Kim, J | 1 |
| Shigetomi, S | 1 |
| Tanaka, K | 1 |
| Yamada, ZO | 1 |
| Hashimoto, S | 1 |
| Fukuchi, S | 1 |
| Brozinick, JT | 2 |
| Wilcox, RE | 2 |
| Banks, EA | 1 |
| Cortez, MY | 1 |
| Sternbauer, K | 1 |
| Luthman, J | 1 |
| Hänni, A | 1 |
| Jacobsson, SO | 1 |
| Pan, SJ | 1 |
| Hancock, J | 1 |
| Ding, Z | 1 |
| Fogt, D | 1 |
| Lee, M | 1 |
| Castle, A | 1 |
| Yaspelkis, BB | 1 |
| Kuo, CH | 1 |
11 other studies available for clenbuterol and Insulin Sensitivity
| Article | Year |
|---|---|
In vivo metabolic effects after acute activation of skeletal muscle G
Topics: Animals; Clenbuterol; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; GTP-Binding P | 2022 |
Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells.
Topics: Animals; Biochemical Phenomena; Cellular Reprogramming; Clenbuterol; Female; Glucose; Homeostasis; H | 2022 |
Postnatal β2 adrenergic treatment improves insulin sensitivity in lambs with IUGR but not persistent defects in pancreatic islets or skeletal muscle.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Animals; Atenolol; Cell | 2019 |
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Clenbuterol; Fatty Liver; Glucose; Homeostasis; Insuli | 2020 |
Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle.
Topics: Animals; Citrate (si)-Synthase; Clenbuterol; Deoxyglucose; Female; Glucose Transporter Type 4; Insul | 1995 |
[The role of beta 2-adrenoceptor on the pathogenesis of insulin resistance in essential hypertension].
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Glucose; Blood Pressure; Clenbuterol; Humans; Hypertens | 1994 |
Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle.
Topics: Aerobiosis; Animals; Body Weight; Citrate (si)-Synthase; Clenbuterol; Enzymes; Female; Glucose; Hind | 1993 |
Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats.
Topics: 3-O-Methylglucose; Animals; Biological Transport; Body Weight; Citrate (si)-Synthase; Clenbuterol; D | 1993 |
Clenbuterol-induced insulin resistance in calves measured by hyperinsulinemic, euglycemic clamp technique.
Topics: Animals; Blood Glucose; Bronchodilator Agents; Cattle; Cattle Diseases; Clenbuterol; Glucose; Glucos | 1998 |
Effects of clenbuterol on insulin resistance in conscious obese Zucker rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Clenbuterol; Female; Glucose; Glycoge | 2001 |
Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions.
Topics: 3-O-Methylglucose; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Biologica | 2001 |